Deleterious mutations in the essential mRNA metabolism factor, hGle1, in amyotrophic lateral sclerosis.
about
Inside out: the role of nucleocytoplasmic transport in ALS and FTLDArchitecture of the symmetric core of the nuclear poreTHOC2 Mutations Implicate mRNA-Export Pathway in X-Linked Intellectual DisabilityThe C9orf72 repeat expansion disrupts nucleocytoplasmic transport.Mutant TDP-43 within motor neurons drives disease onset but not progression in amyotrophic lateral sclerosis.GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport.Cytoplasmic hGle1A regulates stress granules by modulation of translation.Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways.Antisense RNA foci in the motor neurons of C9ORF72-ALS patients are associated with TDP-43 proteinopathy.TDP-43 and FUS en route from the nucleus to the cytoplasm.A role for Gle1, a regulator of DEAD-box RNA helicases, at centrosomes and basal bodiesControl of mammalian gene expression by selective mRNA export.Mutant Huntingtin Disrupts the Nuclear Pore Complex.Nucleoporin genes in human diseases.Nuclear transport dysfunction: a common theme in amyotrophic lateral sclerosis and frontotemporal dementia.ALS: Recent Developments from Genetics Studies.Nuclear trafficking in amyotrophic lateral sclerosis and frontotemporal lobar degeneration.Integration of mRNP formation and export.Structure and Function of the Nuclear Pore Complex Cytoplasmic mRNA Export Platform.Calpain-dependent disruption of nucleo-cytoplasmic transport in ALS motor neurons.Chronically stressed or stress-preconditioned neurons fail to maintain stress granule assembly.An amyotrophic lateral sclerosis-linked mutation in GLE1 alters the cellular pool of human Gle1 functional isoforms.Age-Dependent TDP-43-Mediated Motor Neuron Degeneration Requires GSK3, hat-trick, and xmas-2.TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD.Artificial intelligence in neurodegenerative disease research: use of IBM Watson to identify additional RNA-binding proteins altered in amyotrophic lateral sclerosis.ALS Associated Mutations in Matrin 3 Alter Protein-Protein Interactions and Impede mRNA Nuclear Export.Lost in Transportation: Nucleocytoplasmic Transport Defects in ALS and Other Neurodegenerative Diseases.The roles of intrinsic disorder-based liquid-liquid phase transitions in the "Dr. Jekyll-Mr. Hyde" behavior of proteins involved in amyotrophic lateral sclerosis and frontotemporal lobar degeneration.Nup42 and IP6 coordinate Gle1 stimulation of Dbp5/DDX19B for mRNA export in yeast and human cells.RNA Nuclear Export: From Neurological Disorders to Cancer.Dysregulated molecular pathways in amyotrophic lateral sclerosis-frontotemporal dementia spectrum disorder.Gle1 regulates RNA binding of the DEAD-box helicase Ded1 in its complex role in translation initiation.Ageing as a risk factor for ALS/FTD.MCM3AP in recessive Charcot-Marie-Tooth neuropathy and mild intellectual disability.Polyglutamine-Expanded Huntingtin Exacerbates Age-Related Disruption of Nuclear Integrity and Nucleocytoplasmic Transport.Expansion of the GLE1-associated arthrogryposis multiplex congenita clinical spectrum.ANXA11 mutations prevail in Chinese ALS patients with and without cognitive dementia.Dysfunction of Optineurin in Amyotrophic Lateral Sclerosis and Glaucoma.Structural and functional analysis of mRNA export regulation by the nuclear pore complex.Depletion of mRNA export regulator DBP5/DDX19, GLE1 or IPPK that is a key enzyme for the production of IP6, resulting in differentially altered cytoplasmic mRNA expression and specific cell defect.
P2860
Q26748482-292D84C0-4B23-4A25-9D83-F8FB84A725CFQ27704606-D5100BE1-81AC-4061-B106-0B10DD73954EQ28117236-3BCA1CCC-3914-40FA-B9EE-8A279EF941DDQ29871482-D7CB3C0D-1E3B-422D-9314-321DA83876DCQ30848992-76466A8E-4E39-4C40-934B-7EB5964F1277Q34491033-F7778DA7-A235-49F8-B059-E7530441E1E3Q35390122-30B3FBB3-64CC-42DC-A91A-1B4FB2081DA4Q35624305-BF83AA5A-ADF8-4965-9955-95993E8A4B2BQ35746397-8ACABA57-0F84-44BC-AC0D-83176A0B8C74Q36336278-6A06DED7-B49C-47F2-8524-4461BD39FDF8Q37573354-66E53E4F-DB06-4790-98A8-D4A299541034Q38529724-6F34BBFB-A516-41EE-B654-5C96FC3648FEQ38734025-782ADCCA-AB1E-4271-95F1-ECC7144798B2Q38806487-A9B97E33-0E30-4EC7-BD3A-2E6EAA678925Q38810478-6985D08F-4E8D-4092-AA15-F2453BC681CCQ38817325-07F02284-B1B4-4A56-B1CA-927A820ED0DAQ38920545-59D5765E-557C-4E3C-B1C1-AFDFE98BE936Q39185469-2CB593A9-610F-42EF-83B7-54CE00632212Q39191547-C3599DE2-423A-4347-AED3-818E7CABBF9DQ40548161-79F72F33-7853-47B9-A98D-9180ADC41D35Q41082653-1573685B-D837-418C-B5DC-A4203A3E025FQ41428389-A9E9E16B-B2A3-4DE2-9EB9-0BFECC8D6517Q42558042-629A7F9A-6F7A-4DEC-80B3-5FC4BB0B36ABQ47194986-EE4E1DDD-FC6A-41A5-BBFA-28E902697FC4Q47406275-F5796D01-259D-4873-946E-DF0C185743DFQ47433707-BA5327AF-A116-4615-813F-4C317B277CEAQ47661814-55EF9821-B280-443D-A4CC-F0F13C56C509Q47693846-08EE8CD8-537B-4A0D-AF40-051D65402A58Q47860243-D5189DAF-36B3-4FB8-983B-D8CE44C59C9AQ47907249-BB56DCE8-41ED-4D52-BB92-C1DBE14B6C65Q47946104-5531C215-9533-4790-B698-95C4088BA96EQ47981764-84AC37F8-F437-4729-B268-AE12977C7D35Q49608524-0834CD70-4534-4ABF-A9BD-E3E301FF52FBQ50933525-2832993F-E5E9-4CCE-86AF-A5DEC6300815Q51068766-FFEB16D7-28C4-4DA9-8332-519B68A8A763Q51449678-CDDC1B48-9BB4-4539-81D8-765CD1F2E687Q55002878-F9D63C2F-D394-4089-BD81-09FEF7BBC3CDQ55261436-532D6785-12C4-4081-AD3A-3BCF92C07FA5Q55272570-630DBFCB-78C5-4289-A15E-4F37A6F60B8EQ55333258-C6F9B451-1284-480B-8AC9-2DF9C85EFA62
P2860
Deleterious mutations in the essential mRNA metabolism factor, hGle1, in amyotrophic lateral sclerosis.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Deleterious mutations in the e ...... amyotrophic lateral sclerosis.
@ast
Deleterious mutations in the e ...... amyotrophic lateral sclerosis.
@en
type
label
Deleterious mutations in the e ...... amyotrophic lateral sclerosis.
@ast
Deleterious mutations in the e ...... amyotrophic lateral sclerosis.
@en
prefLabel
Deleterious mutations in the e ...... amyotrophic lateral sclerosis.
@ast
Deleterious mutations in the e ...... amyotrophic lateral sclerosis.
@en
P2093
P2860
P50
P356
P1476
Deleterious mutations in the e ...... amyotrophic lateral sclerosis.
@en
P2093
Andrew W Folkmann
Anna Szuto
Anne Noreau
Annie Levert
Catherine André-Guimont
Claire S Leblond
Daniel Rochefort
Hannah M Kaneb
Hussein Daoud
P2860
P304
P356
10.1093/HMG/DDU545
P577
2014-10-24T00:00:00Z